Essex Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
13,824
-584
-4% -$55.9K 0.07% 250
2025
Q4
$1.38M Sell
14,408
-145
-1% -$14.1K 0.08% 211
2025
Q3
$1.39M Buy
14,553
+504
+4% +$46.3K 0.08% 208
2025
Q2
$1.22M Sell
14,049
-1,626
-10% -$138K 0.08% 219
2025
Q1
$1.41M Buy
15,675
+3,350
+27% +$300K 0.1% 180
2024
Q4
$985K Sell
12,325
-312
-2% -$27K 0.07% 237
2024
Q3
$1.15M Sell
12,637
-1,403
-10% -$118K 0.08% 210
2024
Q2
$1.15M Buy
14,040
+2,231
+19% +$183K 0.09% 211
2024
Q1
$1.03M Sell
11,809
-463
-4% -$39.5K 0.09% 203
2023
Q4
$1.01M Sell
12,272
-3,371
-22% -$257K 0.1% 186
2023
Q3
$1.23M Buy
15,643
+2,001
+15% +$168K 0.14% 148
2023
Q2
$1.2M Buy
13,642
+182
+1% +$15.7K 0.14% 153
2023
Q1
$1.09M Buy
13,460
+929
+7% +$75.7K 0.11% 170
2022
Q4
$973K Sell
12,531
-432
-3% -$35K 0.1% 187
2022
Q3
$1.05M Buy
12,963
+31
+0.2% +$2.79K 0.12% 152
2022
Q2
$1.16M Sell
12,932
-279
-2% -$28.3K 0.13% 154
2022
Q1
$1.47M Sell
13,211
-337
-2% -$35.6K 0.14% 152
2021
Q4
$1.4M Buy
13,548
+7
+0.1% +$811 0.14% 158
2021
Q3
$1.7M Buy
13,541
+2,540
+23% +$329K 0.19% 123
2021
Q2
$1.3M Hold
11,001
0.19% 116
2021
Q1
$1.3M Sell
11,001
-3,538
-24% -$415K 0.23% 101
2020
Q4
$1.7M Sell
14,539
-1,810
-11% -$199K 0.34% 71
2020
Q3
$1.7M Buy
16,349
+404
+3% +$40.6K 0.42% 57
2020
Q2
$1.46M Buy
15,945
+439
+3% +$42.1K 0.45% 58
2020
Q1
$1.4M Sell
15,506
-93
-0.6% -$9.89K 0.5% 51
2019
Q4
$1.77M Buy
15,599
+1,356
+10% +$149K 0.49% 60
2019
Q3
$1.55M Sell
14,243
-211
-1% -$22K 0.5% 60
2019
Q2
$1.41M Sell
14,454
-1,006
-7% -$91.8K 0.42% 65
2019
Q1
$1.41M Sell
15,460
-2,162
-12% -$194K 0.43% 63
2018
Q4
$1.6M Sell
17,622
-1,723
-9% -$161K 0.49% 56
2018
Q3
$1.9M Buy
19,345
+64
+0.3% +$5.92K 0.42% 69
2018
Q2
$1.65M Buy
19,281
+487
+3% +$40.7K 0.4% 67
2018
Q1
$1.51M Sell
18,794
-722
-4% -$59.6K 0.3% 96
2017
Q4
$1.58M Sell
19,516
-736
-4% -$58.9K 0.37% 69
2017
Q3
$1.57M Buy
20,252
+13,785
+213% +$1.14M 0.39% 69
2017
Q2
$503K Sell
6,467
-8,264
-56% -$697K 0.11% 189
2017
Q1
$1.19M Sell
14,731
-2,125
-13% -$166K 0.27% 93
2016
Q4
$1.2M Sell
16,856
-3,345
-17% -$263K 0.26% 95
2016
Q3
$1.75M Sell
20,201
-683
-3% -$59.5K 0.42% 65
2016
Q2
$1.81M Buy
20,884
+108
+0.5% +$8.73K 0.44% 62
2016
Q1
$1.56M Sell
20,776
-104
-0.5% -$7.83K 0.39% 67
2015
Q4
$1.61M Sell
20,880
-1,417
-6% -$107K 0.39% 68
2015
Q3
$1.49M Buy
22,297
+232
+1% +$17.1K 0.39% 67
2015
Q2
$1.64M Buy
+22,065
New +$1.69M 0.42% 64
2015
Q1
Sell
-17,795
Closed -$1.28M 333
2014
Q4
$1.28M Buy
17,795
+2,938
+20% +$204K 0.33% 76
2014
Q3
$920K Buy
14,857
+900
+6% +$57.2K 0.28% 89
2014
Q2
$890K Sell
13,957
-539
-4% -$32.7K 0.27% 91
2014
Q1
$892K Buy
14,496
+16
+0.1% +$932 0.29% 81
2013
Q4
$831K Sell
14,480
-300
-2% -$17K 0.28% 90
2013
Q3
$787 Buy
14,780
+3,125
+27% +$168K 0.25% 88
2013
Q2
$600K Buy
+11,655
New +$576K 0.21% 111

Other funds holding MDT

Essex Financial Services's MDT Position: Q1 2026 in Review

Essex Financial Services reduced its Medtronic (MDT) stake by 4.1% in Q1 2026, selling an estimated $55.9K and leaving 13,824 shares worth $1.2M. The position accounts for 0.07% of the portfolio, ranked #250.

Essex Financial Services first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.9M in Q3 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Essex Financial Services held 13,824 shares of Medtronic worth $1.2M as of Q1 2026.
  • Essex Financial Services sold 584 Medtronic shares in Q1 2026, an estimated $55.9K.
  • Medtronic made up 0.07% of Essex Financial Services's portfolio in Q1 2026, its #250 holding.
  • Essex Financial Services first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • Essex Financial Services's Medtronic position peaked at $1.9M in Q3 2018.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.